Package 0409-0186-01

Brand: gemcitabine

Generic: gemcitabine
NDC Package

Package Facts

Identity

Package NDC 0409-0186-01
Digits Only 0409018601
Product NDC 0409-0186
Product ID 0409-0186_111b13bb-6793-4b33-b845-0dc9b46837de
Description

1 VIAL, SINGLE-DOSE in 1 CARTON (0409-0186-01) / 25 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2011-07-26
Brand gemcitabine
Generic gemcitabine
Sample Package No

Linked Drug Pages (1)

Gemcitabine ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "111b13bb-6793-4b33-b845-0dc9b46837de", "openfda": {"unii": ["U347PV74IL"], "rxcui": ["1719000", "1719003"], "spl_set_id": ["d16907e7-a8c8-4039-ace4-cf4e24ba68c0"], "manufacturer_name": ["Hospira, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (0409-0186-01)  / 25 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "0409-0186-01", "marketing_start_date": "20110726"}], "brand_name": "Gemcitabine", "product_id": "0409-0186_111b13bb-6793-4b33-b845-0dc9b46837de", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "0409-0186", "generic_name": "GEMCITABINE", "labeler_name": "Hospira, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Gemcitabine", "active_ingredients": [{"name": "GEMCITABINE HYDROCHLORIDE", "strength": "38 mg/mL"}], "application_number": "ANDA078339", "marketing_category": "ANDA", "marketing_start_date": "20110726", "listing_expiration_date": "20261231"}